Shares of Glenmark Pharma touched 52-week low of Rs 483.60, falling 9 percent in the opening trade on Wednesday on the back of poor fourth quarter numbers.
The company has reported 17.5 percent fall in its Q4 net profit at Rs 151.6 crore against Rs 183.7 crore in the same quarter last fiscal.
Revenue of the company was down 7 percent at Rs 2,279.8 crore against Rs 2,457.7 crore
The operating profit or EBITDA of the company was down 26 percent at Rs 326.8 crore and margin was at 14.3 percent.The board has recommended dividend at 200 percent i.e. Rs 2 per share for the financial year 2017-2018.
Read more--Stocks update
No comments:
Post a Comment